Israel’s life science technology plays a leading role globally. On Aug 15, Israeli companies came to 2016 Israel Life Science Technology (Changzhou) Promotion Seminar with over 40 projects in the fields of bio-medicine, medical instrument, digital medical treatment, medical care, etc., to seek cooperative partners. And they made talks with more than 80 enterprises in Changzhou.

In recent years, the construction of bio-medicine and high-performance medical instrument, which is regarded as one of the five key fields of “China Manufacturing 2025” Changzhou Outline, has been expedited. In 2015, the output of new medicine industry of Changzhou exceeded 40 billion RMB, boasts more than 80 various sorts of enterprises and R&D institutes, and formed an industrial cluster with stronger competitiveness and creativity.

Changzhou and Israel have a good foundation of economic and science and technology cooperation. And Sino-Israel Changzhou Innovation Park has become a vital innovative carrier of blending into global network and building Southern-

Jiangsu National Innovation Model Zone. Till this June, the park has signed 13 new Israel projects and attracted altogether 50 well known Israeli enterprises like Hanita, Hobart, Emefcy and Natali.

It is said that the 40 projects brought by Israeli companies boasts hi-tech, broad prospect, and most of them have been in the R&D and clinical stage, and some has begun to make profits.